Skystar Bio-pharmaceutical Co (SKBI) financial statements (2021 and earlier)

Company profile

Business Address RM 10601, JIEZUO PLAZA, NO. 4
XIAN PROVINCE, 00000
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments811
Cash and cash equivalents811
Receivables1111
Inventory, net of allowances, customer advances and progress billings2623
Inventory2623
Prepaid expense2
Advances on inventory purchases4123
Deposits current assets0 
Prepaid expense and other current assets3
Deferred tax assets0 
Other undisclosed current assets(0) 
Total current assets:8972
Noncurrent Assets
Property, plant and equipment2829
Intangible assets, net (including goodwill)55
Intangible assets, net (excluding goodwill)55
Prepaid expense5
Prepaid expense and other noncurrent assets1
Other undisclosed noncurrent assets(28)(29)
Total noncurrent assets:107
Other undisclosed assets3838
TOTAL ASSETS:136116
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities56
Accounts payable34
Accrued liabilities0 
Taxes payable12
Debt114
Due to related parties11
Other undisclosed current liabilities86
Total current liabilities:2517
Noncurrent Liabilities
Liabilities, other than long-term debt11
Deferred revenue and credits11
Derivative instruments and hedges, liabilities00
Other undisclosed noncurrent liabilities 1
Total noncurrent liabilities:12
Total liabilities:2620
Stockholders' equity
Stockholders' equity attributable to parent, including:11096
Common stock00
Additional paid in capital3837
Accumulated other comprehensive income129
Retained earnings5545
Other undisclosed stockholders' equity attributable to parent66
Total stockholders' equity:11096
TOTAL LIABILITIES AND EQUITY:136116

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Revenues
(Revenue, Net)
4234
Cost of revenue
(Cost of Goods and Services Sold)
(23)(17)
Other undisclosed gross profit22
Gross profit:2118
Operating expenses(8)(10)
Operating income:139
Nonoperating expense(0)(0)
Investment income, nonoperating(0)0
Other nonoperating income00
Income from continuing operations before income taxes:138
Income tax expense(2)(2)
Net income available to common stockholders, diluted:116

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net income:116
Comprehensive income:116
Other undisclosed comprehensive income, net of tax, attributable to parent31
Comprehensive income, net of tax, attributable to parent:147

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: